{"transactions":[{"id":3542115,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":157947,"kind":"person","name":"RINGROSE PETER S","position":1,"cik":"0001199298","reported_name":"RINGROSE PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2019-05-02T18:32:20.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":23.85,"expiration_date":"2029-04-29","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-19-005467","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1199298/000117911019005467/edgar.xml","form_type":"4"}},{"id":3542114,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":157947,"kind":"person","name":"RINGROSE PETER S","position":1,"cik":"0001199298","reported_name":"RINGROSE PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-05-02T18:32:20.000Z","date":"2019-04-30","kind":"grant","acquired":true,"shares":8385,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37999,"source":{"system":"sec-edgar","filing":"0001179110-19-005467","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199298/000117911019005467/edgar.xml","form_type":"4"}},{"id":3926190,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":157947,"kind":"person","name":"RINGROSE PETER S","position":1,"cik":"0001199298","reported_name":"RINGROSE PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-19T01:37:52.000Z","date":"2018-05-17","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares shall vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors."}],"balance_after":40000,"derivative":{"exercise_price":3.98,"expiration_date":"2028-05-17","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001179110-18-007154","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911018007154/edgar.xml","form_type":"4"}},{"id":3947089,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":157947,"kind":"person","name":"RINGROSE PETER S","position":1,"cik":"0001199298","reported_name":"RINGROSE PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2018-05-03T18:17:56.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date."}],"balance_after":6000,"derivative":{"exercise_price":24.43,"expiration_date":"2028-04-30","underlying":"Ordinary Shares","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-18-006194","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1199298/000117911018006194/edgar.xml","form_type":"4"}},{"id":3947088,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":157947,"kind":"person","name":"RINGROSE PETER S","position":1,"cik":"0001199298","reported_name":"RINGROSE PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-05-03T18:17:56.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":8186,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":29614,"source":{"system":"sec-edgar","filing":"0001179110-18-006194","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199298/000117911018006194/edgar.xml","form_type":"4"}},{"id":4313321,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":157947,"kind":"person","name":"RINGROSE PETER S","position":1,"cik":"0001199298","reported_name":"RINGROSE PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-05-18T18:05:15.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21428,"source":{"system":"sec-edgar","filing":"0001179110-17-007545","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1199298/000117911017007545/edgar.xml","form_type":"4"}},{"id":4323103,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":157947,"kind":"person","name":"RINGROSE PETER S","position":1,"cik":"0001199298","reported_name":"RINGROSE PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-12T22:05:53.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest monthly over twelve (12) months from the date of grant."}],"balance_after":40000,"derivative":{"exercise_price":2.61,"expiration_date":"2027-05-12","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001179110-17-007134","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000117911017007134/edgar.xml","form_type":"4"}}]}